Search research articles
Contact Us
Filters
Showing results (111-120 of 117) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 117 results.
Leukemia Research
|
January 1, 1986
T-cell involvement in benign phase chronic myelogenous leukemia
R Nogueira-Costa, G Spitzer, S Khorana, et al.
British Journal of Cancer
|
November 29, 2012
Reply to comment on: 'Second to fourth digit ratio (2D:4D), breast cancer risk factors, and breast cancer risk: a prospective cohort study'
D C Muller, L Baglietto, J T Manning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1984
Clinical features and results of management of superior vena cava syndrome secondary to lymphoma
R Perez-Soler, P McLaughlin, W S Velasquez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1986
Tumor burden assessment and its implication for a prognostic model in advanced diffuse large-cell lymphoma
S Jagannath, W S Velasquez, S L Tucker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1994
Long-term prognostic importance of primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large-cell lymphoma
J E Romaguera, J T Manning, C S Tornos, et al.
Leukemia
|
May 24, 2003
Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy
A-M Tsimberidou, H M Kantarjian, E Estey, et al.
Annals of Internal Medicine
|
July 27, 1999
Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial
G Steinbach, R Ford, G Glober, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 117) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 117 results.
Leukemia Research
|
January 1, 1986
T-cell involvement in benign phase chronic myelogenous leukemia
R Nogueira-Costa, G Spitzer, S Khorana, et al.
British Journal of Cancer
|
November 29, 2012
Reply to comment on: 'Second to fourth digit ratio (2D:4D), breast cancer risk factors, and breast cancer risk: a prospective cohort study'
D C Muller, L Baglietto, J T Manning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1984
Clinical features and results of management of superior vena cava syndrome secondary to lymphoma
R Perez-Soler, P McLaughlin, W S Velasquez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1986
Tumor burden assessment and its implication for a prognostic model in advanced diffuse large-cell lymphoma
S Jagannath, W S Velasquez, S L Tucker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1994
Long-term prognostic importance of primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large-cell lymphoma
J E Romaguera, J T Manning, C S Tornos, et al.
Leukemia
|
May 24, 2003
Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy
A-M Tsimberidou, H M Kantarjian, E Estey, et al.
Annals of Internal Medicine
|
July 27, 1999
Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial
G Steinbach, R Ford, G Glober, et al.
Page
of 12